DryShips, Inc. (NASDAQ:DRYS) shares increased 9.37% in last trading session and ended the day at $0.17. DRYS Gross Margin is 56.90% and its has a return on assets of -37.50%. DryShips, Inc. (NASDAQ:DRYS) quarterly performance is -13.05%.
DryShips, Inc. (NASDAQ:DRYS) announced that a special meeting of the Company’s shareholders (the “Special Meeting”) will be held at the Company’s offices located at 109 Kifisias Avenue & Sina Street, GR 151 24, Marousi, Athens, Greece on Friday, February 19, 2016 at 4:00 p.m., local time.
Potash Corporation of Saskatchewan Inc. (NYSE:POT) shares fell -1.83% in last trading session and ended the day at $17.12. POT Gross Margin is 38.50% and its has a return on assets of 8.30%. Potash Corporation of Saskatchewan Inc. (NYSE:POT) quarterly performance is -11.56%.
Potash Corporation of Saskatchewan Inc. (NYSE:POT) announced that its Board of Directors has declared a quarterly dividend of US $0.38 per share payable February 4, 2016 to shareholders of record January 14, 2016.
Ericsson (NASDAQ:ERIC) caters to the Technology space. It has a net profit margin of 4.40% and weekly performance is -1.84%. On the last day of trading company shares ended up at $9.61. Ericsson (NASDAQ:ERIC) distance from 50-day simple moving average (SMA50) is -3.74%.
Ericsson (NASDAQ:ERIC) has officially inaugurated its Mena region’s first telecom equipment hardware and software distribution centre in Dubai South, UAE. The ribbon cutting ceremony was under the patronage of Sheikh Ahmed bin Saeed Al Maktoum, chairman, and chief executive Emirates Airline and Group Dubai Aviation City and Khalifa Al Zaffin, executive chairman, Dubai Aviation City Corporation.
Costamare Inc. (NYSE:CMRE) shares increased 8.09% in last trading session and ended the day at $10.42. CMRE Gross Margin is 74.30% and its has a return on assets of 4.50%. Costamare Inc. (NYSE:CMRE) quarterly performance is -11.81%.
Zacks Investment Research lowered shares of Costamare Inc (NASDAQ:CMRE) from a hold rating to a sell rating in a research report published on Wednesday morning, AnalystRatings.Net reports.
Flamel Technologies SA (NASDAQ:FLML) caters to the Healthcare space. It has a net profit margin of -47.20% and weekly performance is -19.14%. On the last day of trading company shares ended up at $12.21. Flamel Technologies SA (NASDAQ:FLML) distance from 50-day simple moving average (SMA50) is -11.11%.
On 22 December, Flamel Technologies SA (NASDAQ:FLML) announced positive interim results from a Phase 1a clinical trial in healthy volunteers of a once weekly subcutaneous injection formulation of exenatide using its proprietary Medusa™ technology (FT228). The study achieved all safety and pharmacokinetic (PK) assessment objectives throughout ascending single dose administrations of FT228. Exenatide is a GLP1 analog used to treat patients suffering from Type 2 Diabetes Mellitus.